85results about How to "Relieve cough" patented technology

The invention discloses an oral administration pharmaceutical composition for treating phthisis, wherein the active constituents include the following raw material herbs (by weight portion): donkey-hide gelatin 35g, astragalus root 20g, root of pilose asiabell 25g, poria cocos wolf 15g, Chinese yam 20g, lotus seed 12g, adenophora root 25g, ophiopogon root 25g, Sichuan fritillary bulb 12g, roor of sessile stemona 25g, white atractylodes rhizome 15g and mahonia stem 12g.

The invention provides a traditional Chinese medicine composition for treating a plurality of cancers. 37 traditional Chinese medicine components such as night shade seeds, Shouguan, airpotato yam, Indian iphigenia bulb, Chinese Paris rhizome, herba patriniae, blister beetles, herba scutellariae barbatae, oldenlandia diffusa, zedoary, glossy privet fruit, dung beetles and trichosanthis fructus are subjected to impurity removal respectively, dried, mixed and ground so as to prepare the composition. The composition is characterized in that the composition completely selects a pure natural medicinal formulation, is prepared through a traditional process, and has the functions of regulating the immunity of human bodies, strengthening the metabolic activity of the human bodies, killing cancer cells, protecting normal healthy organism cells and promoting rehabilitation after diseases. The composition is applicable to the clinical treatment of different tumors, particularly liver cancer, lung cancer, esophagus cancer, gastric cancer and the like, has the effective rate of 94.7 percent and the cure rate of 86 percent, and has the effects of no metastasis and no relapse.

The invention discloses a traditional Chinese preparation with the effects of clearing heat, eliminating phlegm, moistening lung and relieving cough. The capsule utilizes bulbus fritilariae, rhizoma anemarrhenae, scutellaria baicalensis, rhizoma coptidis, aster, snakegourd seed, peucedanum root, dried tangerine peel, platycodon grandiflorum, the root bark of white mulberry, mentha haplocalyx and liquorice as raw materials, and is prepared through the working processes of pulverization, decoction, filtration, concentration, drying, sieving, and the like. The invention has obvious effects on cough with lung heat, pharyngalgia and excessive phlegm.

The invention discloses a traditional Chinese medicinal composition for treating bronchial asthma, and belongs to the field of traditional Chinese medicines. The traditional Chinese medicinal composition is prepared from the following bulk drugs by weight: 30g of astragalus membranaceus, 30g of rhizoma atractylodis macrocephalae, 25g of divaricate saposhnikovia root, 10g of semen brassicae, 10g of honeysuckle, 10g of scutellaria baicalensis, 10g of schisandra chinensis, 10g of raw gypsum, 10g of perilla fruit, 10g of pinellia ternata, 10g of prepared rehmannia, 10g of apricot kernel, 10g of cicada slough, 10g of earthworm, 10g of dried tangerine peel, 6g of bulbus fritillariae cirrhosae, 6g of ephedra, 6g of platycodon grandiflorum, 2g of asarum, 8g of raw ginger, 5g of Chinese date, and 4g of roasted liquorice. The traditional Chinese medicinal composition has the effects on freeing lung and clearing heat, eliminating phlegm and clearing pus, warming middle-jiao and expelling cold, and calming panting and suppressing cough, fundamentally solves medical problems that asthma relapses and cannot be healed after long-time treatment, and can achieve the aim of treating both symptoms and root causes without any side effect.

The invention belongs to the field of traditional Chinese medicine preparations, and provides a formula of paste for treating asthma diseases, as well as a preparation method and application thereof. The formula comprises donkey-hide gelatin and medicinal raw materials; due to the unique combination, the original medicinal effects of the medicinal raw materials can be achieved, and the curative effect of the medicinal raw materials can be further enhanced after the medicinal raw materials are combined. The paste can be used for effectively relieving gasp, dyspnea, chest distress, cough, sticky phlegm with cough distress, spontaneous perspiration and weakness, spleen-stomach deficiency and other symptoms of patients with bronchial asthma in the catabatic period. Furthermore, the paste is a pure traditional Chinese medicine preparation, does not have toxic or side effect, can be easily accepted by patients in comparison with western medicinal treatment effect for asthma in the prior art, and can be widely applied to treatment of bronchial asthma in the catabatic period.

The invention discloses a pharmaceutical composition for relieving cough and asthma. The pharmaceutical composition consists of the following materials: 6-18 parts of semen armeniacae amarae, 6-18 parts of perilla fruits, 15-28 parts of radix stemonae, 15-28 parts of tussilago farfara, 10-24 parts of aster, 10-24 parts of birthwort, 10-24 parts of loquat leaves, 6-18 parts of white mulberry root-barks, 8-16 parts of semen lepidii, 2-10 parts of ginkgoes, 2-10 parts of ginkgoes, 2-10 parts of ardisia japonica, 2-10 parts of flos daturae, 8-16 parts of physochlaina macrophylla, 15-28 parts of folium rhododendri daurici, 22-38 parts of thorny elaeagnus leaves, and 10-24 parts of momordica grosvenori. A dosage form of the pharmaceutical composition can be medically acceptable dosage forms such as capsule, tablet, spray and decoction, wherein the preparation method for the dosage forms and dosage amount of auxiliary materials are carried out according to the normal process. The pharmaceutical composition disclosed by the invention overcomes the defects of the existing drugs for relieving cough and asthma; the pharmaceutical composition with good effects for treating bronchitis and asthmatic bronchitis is provided, curative effect temperature and toxic and side effect are relatively lower.

The present invention has shown that not all salts of pyruvic acid enhance lung functions or enhance the synthesis of lung surfactants and that certain salts of pyruvic acid with the correct concentrations of calcium, phosphate and magnesium, is are synergistic in their ability to enhance the synthesis of lung surfactants that will enhance lung alveoli functions, while decreasing coughing and lung tightness, and increasing oxygen saturation values to prevent hypoxemia. This patent demonstrates that the sodium pyruvate formula with calcium, phosphate and magnesium was superior over standard sodium pyruvate formula in saline alone in the removal of mucus, reduction of lung or sinus infections, and in reducing drug side effects and congestion. The use of this formula clearly demonstrated that it can be used to produce better efficacy in patients with hypoxemia, with lung and sinus diseases including, asthma, COPD, cystic fibrosis, interstitial lung disease, allergic rhinitis, sinusitis, Alzheimer's, disease, Parkinson's disease, brain trauma, nicotine addiction, sleep apnea, autism, migraine headaches, sleep disorders, lung and sinus infections, cancer therapy with cancer drugs, nicotine addiction, and medications that cause a decrease in lung surfactants.

The invention relates to a special Chinese patent medicine for resisting phthisis-astragalus fritillaria capsules, which is prepared from 120-150g of radix astragali, 20-50g of aweto, 80-100g of gecko, 50-80g of fritillaria cirrhosa, 50-70g of stemona, 48-70g of lily root, 30-50g of ginkgo, 56-76g of hyacinth bletilla, 120-150g of coix seed, 20-50g of radix glehniae, 80-102g of radix rehmanniae preparata, 60-85g of radix ophiopogonis, 55-75g of tuckahoe, 80-130g of taraxacum and 60-75g of oyster. The Chinese patent medicine not only can be made into capsules according to the formula of the composition, but also can be made into tablets, pills, powder and oral liquids according to the formula of the composition. The capsules are prepared from Chinese medicinal herbs, and can treat tuberculosis (mainly phthisis) by utilizing the comprehensive conditioning actions of the Chinese medicinal herbs; the capsules can not generate toxic or side effect, and also can not generate drug resistance, and the effective rate is up to more than 95%; and the capsules can be combined with other antituberculosis medicines to enhance the curative effect (especially for drug-resistant strain infected cases), and can also be independently used for patients who are allergic to western antituberculosis medicines or can not stand for the toxic or side effect.

The invention provides a tobramycin solution for inhalation. The tobramycin solution is prepared from tobramycin and a pH regulator, wherein the tobramycin is dissolved in a sodium chloride aqueous solution with concentration of 2.25-4.5mg/ml, the concentration of the tobramycin is 60-75 mg/ml, the pH regulator is sulfuric acid, and pH of the tobramycin solution for inhalation is 5.8-6.2. The tobramycin solution for inhalation is simple in composition, pH of the solution is controlled to be near-neutral and osmotic pressure is near-isotonic by controlling dosage of sulfuric acid, and bronchospasm and cough caused by irritation of the tobramycin solution for inhalation are reduced; after the tobramycin solution for inhalation is stored at room temperature for 1 year, the content of tobramycin is reduced slightly, the content of related substances is lower than 1.0%, requirements of the USP (United States Pharmacopeia) for the tobramycin solution for inhalation are met, the problem thatthe conventional tobramycin solution for inhalation is required to be stored at 2-8 DEG C is solved, drug use for a patient is facilitated, and storage cost and transport cost are reduced.

The invention discloses atomized liquid for stopping asthma and eliminating phlegm, and belongs to the technical field of Chinese medicaments. The atomized liquid is prepared by decocting the following efficacy components in part by weight: 200 to 1,800 parts of snakegourd seed, 100 to 900 parts of arisaema cum bile, 100 to 1,200 parts of balloon flower, 300 to 3,500 parts of gypsum, 50 to 2,500 parts of ephedra herb, 100 to 1,500 parts of almond and 90 to 2,000 parts of stemona. The atomized liquid has quick response and a good curative effect. The preparation method comprises the following steps of: respectively decocting the efficacy components for three times by a decocting method; merging the decoction obtained from the three times; preparing thick paste by precipitating, filtering, heating and concentrating; adding ethanol after cooling; standing and taking liquid supernatant; recovering the ethanol; adding natrium benzoicum; adding extracted distillate to a full dose; and obtaining a product by refrigerating and filtering. The preparation method is simple and easy to implement.

The invention provides an anti-allergy asthma-relieving tea. The anti-allergy asthma-relieving tea is characterized by comprising the following raw materials by weight: 15 to 20 parts of trichosanthes root, 20 to 25 parts of milkvetch root, 15 to 20 parts of cicada slough, 18 to 23 parts of bitter apricot kernel, 9 to 15 parts of balloonflower root, 10 to 13 parts of hogfennel root, 15 to 25 parts of Zhejiang fritillaria bulb, 15 to 18 parts of red sage root, 20 to 25 parts of pseudostellaria root, 20 to 28 parts of licorice, 15 to 20 parts of ginger processed pinellia tuber and 20 to 30 parts of heartleaf houttuynia herb. The above-mentioned 12 traditional Chinese medicines are easily available and need low cost; the anti-allergy asthma-relieving tea exerts the effects of diffusing the lung, relieving cough, eliminating phlegm by cooling and reducing phlegm to depress Qi when people drinking the tea; and the anti-allergy asthma-relieving tea is convenient to use and easy to carry, causes no anaphylactic reaction and has no toxic and side effects.

The invention discloses externally applied traditional Chinese medicine powder for treating cold, which is characterized in that the externally applied traditional Chinese medicine powder comprises the following traditional Chinese medicine components by weight: 19 to 23% parts of evodia rutaecarpa, 15 to 19% of cinnamon, 9 to 12% of sinapsis alba, 17 to 21% of asarum herb, 10 to 15% of euphorbia kansui, 11 to 15% of rhizoma typhoon, and 7 to 17% of flour. According to the invention, all traditional Chinese medicine components are crushed into fine powder, and then the powder is mixed with the flour to obtain traditional Chinese medicine powder for treating cold. The traditional Chinese medicine powder for treating cold is for external use based on acupuncture points. Compared with present medicine for treating symptoms including acute fever, cough, snivel, sore throat, and headache caused by cold, the externally applied traditional Chinese medicine powder for treating cold provided in the invention has good treatment effects, can be used conveniently, and brings little suffering to the patient. Besides, the medical expenses are low; the occurrence of toxic side effects and infusion reaction can be avoided. Therefore, the externally applied traditional Chinese medicine powder for treating cold provided in the invention is especially suitable for low-income patients or patients not suitable for injection treatment.

The invention provides an extracting method for extracting desertliving cistanche alcohol extracts in desertliving cistanche peel, a desertliving cistanche alcohol extract obtained according to the method, and use of the desertliving cistanche alcohol extract. The method comprises the following steps: using the desertliving cistanche peel, baking and crushing the desertliving cistanche peel, and performing ultrasonic extraction, ultrafiltration and purification, so as to obtain the desertliving cistanche alcohol extract of which the molecular weight is smaller than 5000 Dalton; performing concerted application on the desertliving cistanche alcohol extract, radish seeds, rhizoma coptidis, Chinese rhubarb, phellodendron, radix salviae miltiorrhizae, rhizoma polygonati, glossy privet fruits and the like, so as to obtain the medical composition disclosed by the invention; researching the medical composition in the respects of treating and preventing radioactive pneumonia for postradiotherapy, improving the organism immunity, and the like. The extracting method disclosed by the invention increases the utilization of desertliving cistanche which belongs to the rare medicinal materials in imminent danger, so that the desertliving cistanche has a higher economic value, and the extracting method provides a medical composition which has the advantages of high efficiency, low toxicity and low cost, and is easy to generalize for vast patients with tumors.

The invention relates to a traditional Chinese medicine composition with golden camellia and radix pueraiae, belonging to the technical field of traditional Chinese medicine preparation. The traditional Chinese medicine composition is prepared from the following components in parts by weight: 20-40 parts of golden camellia, 20-40 parts of hawthorns, 20-40 parts of radix pueraiae, 5-25 parts of dandelion, 5-25 parts of perilla seeds, 5-25 parts of radish seeds, 50-70 parts of honey and 35-55 parts of fructo-oligosaccharide. Normal auxiliary materials are added into the raw materials according to a normal method so as to be prepared into various forms such as a tea bag, a granule and an oral liquid. The traditional Chinese medicine composition not only can be used for supplementing nutritional ingredients needed for the human body, but also can completely adopt medicinal and edible food which is reasonably matched according to the over 20 years of rich medical clinical experience of the inventor as well as the principle of guiding and assisting; the traditional Chinese medicine composition can be used for preventing hypertension, hyperlipidemia, hyperglycemia, high blood hyperviscosity and hyperuricosuria, has a remarkable effect in resisting cardiac insufficiency, tumors and ageing, and is free of toxic or side effect, and can be taken for a long time.

This invention provides a preparation method of fermentation product of Cryptoporus volvatus (Peck) Schear and its clinical use, the said Cryptoporus volvatus (Peck) Schear is cultured on culture medium for fluid fermentation or solid fermentation to obtain mycelium of Cryptoporus volvatus (Peck) Schear, culture supernatant fluid and various metabolins, the culture medium of which contains glucose, maltose, yeast powder, peptone, inorganic salts and vitamins. The said fermentation product can be made into kinds of drug forms to prevent and treat irritability diseases, for example, bronchus asthma, allergic rhinitis, allergic gastroenteritis or ophthalmopathy which is caused by pollen, acarid, mildew or dust. Moreover, it can be used for preventing and treating cough.

A self-carrying device for alleviating the swelling and pain in throat through temperature-adjustable hot compression belongs to the technical field of medical appliances. When a patient who has a bad cold and has a fever, if oral administration is used for treating, the curative effect is slow, especially when people sleep at night, the rest of the patient and the sleep of the family can be affected due to the severe cough caused by the swelling and pain in throat. The technical scheme of the invention is as follows: a zipper (8) is installed on a towel wrapping bag (1), a hot towel padding layer (7) is arranged between the inner part of the towel wrapping bag (1) and a vertical flat silicon rubber hot-water bottle (3), the vertical flat silicon rubber hot-water bottle (3) is arranged in the towel wrapping bag (1) with a temperature tester (2), a water inlet nozzle (6) is fixedly connected and communicated with the vertical flat silicon rubber hot-water bottle (3), a thread plug cover (4) is screwed on the water inlet nozzle (6), and the two ends of an elastic belt ring (5) are respectively and fixedly arranged on the two ends of the towel wrapping bag (1). The self-carrying device has the advantages that due to the use of the device, the curative time is shortened greatly, and the recovery is rapid through the hot compression.

The invention discloses a traditional Chinese medicine for treating acute and chronic bronchitis, belongs to a traditional Chinese medicine prescription, and particularly relates to the traditional Chinese medicine which can be used for simultaneously treating both acute bronchitis and chronic bronchitis. The special medicine is prepared from the root of straight ladybell, common hogfenneI root, bletilla striata, radix stemonae, ephedra, cassia twig, almond, thunberg fritillary bulb, scutellariae radix veta, radix ophiopogonis, platycodon grandiflorum, notopterygium root, radix angelicae tuhuo, rhizoma cimicifugae, radix puerariae, radix paeoniae alba, schisandra chinensis, schizonepeta, radix isatidis, rhizoma phragmitis, roasted mulberry bark, roasted aster, radix aristolochiae and liquorice in proportion. The medicine disclosed by the invention has a good effect in treating trachitis by tonifying spleen and kidney, strengthening the body resistance to eliminate pathogenic factors, improving the health and enhancing the immunity. Due to coordination and combination of the medicines, better general adaptability is achieved to most of patients, so the traditional Chinese medicine is more suitable for industrial production; and in addition, due to the combination of the medicines, the traditional Chinese medicine is suitable for treating the trachitis with lots of symptoms, and the recurrence rate is relatively low after the trachitis is cured.

The invention discloses a drug for a stable stage of chronic obstructive pulmonary diseases and a preparation method thereof. The medicinal effective components are composed of radix astragali preparata, sun-dried ginseng, bulbus Lily, cortex lycii, herba ephedrae preparata, semen armeniacae amarum, rhizoma atractylodis, gecko, bulbus fritillariae thunbergii, seeds of snake gourds, radix trichosanthis, poria cocos, dried orange peels, radix platycodi, rhizoma pinelliae preparata, radix glycyrrhizae preparata, rhizoma alismatis, cortex moutan and radix paeoniae rubra. The drug has the effects of tonifying deficiency (invigorating qi-yin of the lung and invigorating qi of the spleen and kidney), eliminating phlegm, removing dampness, facilitating diuresis, promoting blood circulation, removing blood stasis, nourishing yin, clearing away internal heat, ventilating the lung and unclogging the viscera. The drug can be used in the stable stage of chronic obstructive pulmonary diseases, improve immunity, reduce the frequency of acute aggravation induced by infection, improve the lung function, promote oxygenation, control the disease progress and relieve cough, expectoration, asthma, anddyspnea.

The invention relates to a perfume and in particular relates to a perfume enriched in multiple kinds of essential oil. The perfume comprises the following components in parts by weight: 4-6 percent of essential oil of jasminum, 1-2 percent of sandalwood essential oil, 1-2 percent of birch essential oil, 2-4 percent of cedarwood essential oil, 1-4 percent of rosewood essential oil, 3-4 percent of sweet orange essential oil, 2-4 percent of lime oil, 1.5-2 percent of bitter orange essential oil, 2-6 percent of lavender essential oil, 1-2 percent of peppermint essential oil, 2-4 percent of glycerin, 0.01-0.02 percent of green flower tea, 0.01 percent of evertal, 0.04 percent of grapefruit methane, 0.1 percent of ethyl maltol and the balance of alcohol. The perfume is not added with chemical substances irritating the skin, has the fragrance remaining time of 2-3 days and has the effects of diminishing inflammation, inhibiting bacteria and resisting oxidation, and the product is safe and non-toxic, is not added with any pigment and does not pollute the clothes.

The present invention provides plant extracts, isolated alkaloids, synthetic alkaloids and compositions having antitussive activity. In some preferred embodiments, the plant extracts and the isolated alkaloids are from a plant of a genus in the family Stemonaceae. In other preferred embodiments, the plant extracts and the isolated alkaloids are from a plant of the genus Stemona, Croomia, or Stichoneuron. In especially preferred embodiments, the plant extracts and the isolated alkaloids are from the plant Stemona tuberosa. The present invention further provides methods for isolating such plant extracts and alkaloids. In addition, the present invention provides methods for reducing or suppressing coughing by administering plant extracts, alkaloids and compositions having antitussive activity.

The invention discloses a medicine for treating chronic obstructive pulmonary disease in the stable phase. The medicine is characterized by being prepared from the following medicinal raw materials: pawpaws, prinsepia uniflora batal, semen euryales, pyrola rotundifolia, cipadessa baccifera, tricyrtis root, pseudodrynaria coronans, cinnamomum camphora, parmelia tinctourium, semen aesculi, solanum lyratum thunb and semen lini. Clinical experiments prove that the medicine has the characteristics of good curative effect and relatively high safety when being used for treating chronic obstructive pulmonary disease, and is worthy of clinical application and popularization.